Ron Finklestien
My Annual Public Service Announcement regarding NASS' Weekly Reports
The most irresponsible of all USDA-related reports are NASS’ weekly crop progress/condition updates. To begin with, nobody has an answer for the question, “Percent ...
iShares Select Dividend ETF Experiences Big Outflow
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Select Dividend ETF ...
Microsoft (MSFT) Debuts Copilot+ PCs With AI-Focused Features
Microsoft MSFT recently introduced a revolutionary category of Windows PCs designed for AI called Copilot+ PCs. These devices represent the pinnacle of speed and ...
AutoZone (AZO) Pulls Off a Surprise in Q3 Earnings, Sales Miss
AutoZone Inc. AZO reported earnings of $36.69 per share for third-quarter fiscal 2024 (ended May 4, 2024), up 7.5% year over year. Earnings surpassed the ...
iShares S&P Small-Cap 600 Value ETF Experiences Big Outflow
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares S&P Small-Cap 600 ...
Top Picks: Why TM, ADI, and COST Are Standout Stocks for Next Decade
When considering the best stocks for the next decade of investing, it’s important to remember one thing: no one has a crystal ball. While ...
4 Defense Equipment Stocks to Buy Amid Supply Chain Issues
Steadily improving air traffic across the globe has been boosting the growth prospects of the Zacks Aerospace-Defense Equipment industry stocks. However, persistent supply-chain issues ...
March 2025 Options Now Available For United Airlines Holdings (UAL)
Investors in United Airlines Holdings Inc (Symbol: UAL) saw new options become available today, for the March 2025 expiration. One of the key inputs ...
Pure Storage (PSTG) Is Considered a Good Investment by Brokers: Is That True?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed ...
Roche (RHHBY) Cancer Drug Gets Breakthrough Therapy Designation
Roche RHHBY obtained a Breakthrough Therapy Designation for its investigational oral therapy inavolisib for treating adult breast cancer patients in the United States. The ...
